Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC) — Stella

Recruiting

Back to Esophageal Neoplasms trials

Trial locations(8 sites)

United States

MD Anderson Cancer Center, Houston, Texas

Belgium

Universitair ziekenhuis Gent, Ghent

France

Centre Hospitalier régional Universitaire de Lille, Lille

Ireland

Saint James Hospital, Dublin

Netherlands

Amsterdam UMC, Amsterdam

Key details

Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment target

~10,000 participants

Started

June 2020

Primary completion

March 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov